Article metrics

Original research
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study

 

Online download statistics by month:

Online download statistics by month: July 2021 to September 2021

AbstractFullPdf
Jul 2021283283102
Aug 202132132683
Sep 202120920962
Total813818247